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appendage to prevent left atrial appendage thrombus formation and as adjunctive therapy to treat atrial fibrillation patients (15) . Data suggest that pericardial access for ventricular tachycardia ablations has a major complication rate of 4% to 5% with the most common being early bleeding/early tamponade in 1.8% to 4.4% of all cases (16, 17) . Chest pain is common and can be severe. In 1 series almost all patient had chest pain and were treated with nonsteroidal anti-inflammatory drugs (17) . Chest pain is anticipated to be worse in these procedures given the inflammation caused by the epicardial ablation.
Minor complications included dry right ventricle (RV) puncture ranging from 5% to 17% and access into the pleural space. Pericardial access for the LARIAT device used a similar pericardial approach with 3% to 5% of patients experiencing access-related complications. The most common complication reported was pericarditis ranging from 2.3% to 15%. RV perforation occurred between 1.1% and 5% of cases.
However, the use of a micropuncture needle for pericardial access has resulted in a significant decrease in pericardial access-related complications including RV perforation and tamponade (15, 18 ).
These reports demonstrate the safety of an epicardial approach to deliver advance cardiac therapies with limited complications when using a micropuncture needle rather than a standard pericardiocentesis needle.
Intracoronary and intravenous delivery of novel treatments have been most practical for delivery but 
